FDA Approves Cobenfy for the Treatment of Schizophrenia in Adults
Written by
Reginald Content Writer
Written by
Reginald Content Writer
Isolating IgA-Coated Gut Bacteria Linked to Diseases: Groundbreaking Method Introduced
Surprising Role of Protein Netrin1 in Spinal Cord Development, Scientists Uncover
Repurposed FDA-Approved Drug Could Uncover Potential Treatment for Rare Genetic Disorders
Perspectum Receives FDA Grant to Investigate Biomarker for Rare Disease Treatment
FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency
Study Sheds Light on Liver Damage, Aging, and Multi-Organ Failure
Obesity Medications Show Promise in Reducing Alcohol Consumption Among Those with Alcohol Use Disorder
